Farhan Zameer
Biographic Data
| ID | 8313174 |
|---|---|
| NAME | Farhan Zameer |
| GIVEN NAMES | Farhan |
| FAMILY NAME | Zameer |
| SIGNATURE | ZAMEER F |
| AFFILIATIONS | Dayananda Sagar University |
| ORCID | 0000-0002-4868-1111 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2017 |
| LATEST PUBLICATION YEAR | 2018 |
| H-INDEX | 0 |
Inhibitory Potency of Withania Somnifera Extracts Against DPP-4
Background: Pharmacologic treatments for type 2 diabetes are based upon increasing insulin availability and improving sensitivity to insulin. Nowadays, glucagon like peptide-1 (GLP-1) based therapies aims at glucose control through DPP-4 inhibitors. DPP-4 is a transmembrane glycoprotein belongs to prolyl oligopeptidase family, with the specificity of removing X-Pro or X-Ala dipeptides from the N-terminus of polypeptides. GLP-1 effect by stimulati…
Inhibitory Potency of Withania Somnifera Extracts Against DPP-4
Background: Pharmacologic treatments for type 2 diabetes are based upon increasing insulin availability and improving sensitivity to insulin. Nowadays, glucagon like peptide-1 (GLP-1) based therapies aims at glucose control through DPP-4 inhibitors. DPP-4 is a transmembrane glycoprotein belongs to prolyl oligopeptidase family, with the specificity of removing X-Pro or X-Ala dipeptides from the N-terminus of polypeptides. GLP-1 effect by stimulati…
No prominent works on this page.
Inhibitory Potency of Withania Somnifera Extracts Against DPP-4
Background: Pharmacologic treatments for type 2 diabetes are based upon increasing insulin availability and improving sensitivity to insulin. Nowadays, glucagon like peptide-1 (GLP-1) based therapies aims at glucose control through DPP-4 inhibitors. DPP-4 is a transmembrane glycoprotein belongs to prolyl oligopeptidase family, with the specificity of removing X-Pro or X-Ala dipeptides from the N-terminus of polypeptides. GLP-1 effect by stimulati…
Inhibitory Potency of Withania Somnifera Extracts Against DPP-4
Background: Pharmacologic treatments for type 2 diabetes are based upon increasing insulin availability and improving sensitivity to insulin. Nowadays, glucagon like peptide-1 (GLP-1) based therapies aims at glucose control through DPP-4 inhibitors. DPP-4 is a transmembrane glycoprotein belongs to prolyl oligopeptidase family, with the specificity of removing X-Pro or X-Ala dipeptides from the N-terminus of polypeptides. GLP-1 effect by stimulati…
Biochemistry (2 works) · Chemistry (2 works) · In vitro (2 works) · Medicine (2 works) · Natural Antidiabetic Agents Studies (2 works) · Pharmacology (2 works) · Potency (2 works) · Traditional medicine (2 works) · Withania somnifera (2 works) · Biology (1 work)